Askbio

Established in 2001, Asklepios BioPharmaceutical, Inc. (AskBio) is a privately owned, clinical-phase gene therapy firm committed to enhancing the well-being of individuals with inherited disorders, both children and adults. AskBio's gene therapy system encompasses a cutting-edge in-house cell line production process known as Pro10™ and a comprehensive adeno-associated virus (AAV) capsid and promoter catalogue. Located in Research Triangle Park, North Carolina, the business has produced numerous exclusive third-generation AAV capsids and promoters, a few of which are undergoing clinical trials.